Critical study of regulatory framework associated with Nano medicines across product life cycle in USA.

By:

Material type: Text

TextDescription: ix,73DDC classification:

Dissertation note: 2022 LAKSHMEESHA C.S.

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Call number	Status	Date due	Barcode
ACP-Thesis & Dissertations	Acharya & BM Reddy College of Pharmacy Reference	Acharya & BM Reddy College of Pharmacy	ACP-Drug Regulatory Affairs	615.19 VAI (Browse shelf(Opens below))	Not for loan		ACP-T642

Previous	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available
Previous	615.19MAD A Study of warning letters issued by USFDA TO pharmaceutical companies.	615.19PRI Critical evaluation of the role of product development in the registration of medical devices in European Union.	615.19SAR Comparative study on regulatory framework for adult and hematopoietic stem cells in INDIA and USA.	615.19 VAI Critical study of regulatory framework associated with Nano medicines across product life cycle in USA.

2022 LAKSHMEESHA C.S.

There are no comments on this title.

to post a comment.